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Escherichia coli O78 isolated 
from septicemic lambs shows high 
pathogenicity in a zebrafish model
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Abstract 
The pathogenicity of Escherichia coli O78 strain K46, originally isolated from an outbreak of septicemia in neonatal 
lambs, was investigated in zebrafish embryo and murine models of infection. Its biofilm potential, cellulose pro‑
duction, and the expression of type 1 pili and curli fimbriae were measured by in vitro assays. The strain was highly 
pathogenic in the zebrafish embryo model of infection, where it killed all embryos within 24 h post inoculation 
(hpi) at doses as low as 1000 colony forming units. Zebrafish embryos inoculated with similar doses of commensal 
E. coli strains showed no signs of disease, and cleared the bacteria within 24 h. E. coli K46 colonized the murine gut 
at the same level as the uropathogenic E. coli (UPEC) reference strain CFT073 in CBA/J mice after oral inoculation, 
but infected the murine bladder significantly less than CFT073 after transurethral inoculation. Type 1 pili were clearly 
expressed by E. coli K46, while curli fimbriae and cellulose production were weakly expressed. The ability to produce 
biofilm varied in different growth media, but overall E. coli K46 was a poorer biofilm producer compared to the refer‑
ence strain E. coli UTI89. In conclusion, the zebrafish lethality model provides further evidence that E. coli K46 is highly 
pathogenic and might be useful in future studies to identify bacterial virulence factors.
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(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Though often viewed as inert commensals, some strains 
of Escherichia coli are able to cause disease. Pathogenic 
E. coli are genetically diverse and cause a variety of infec-
tions in animals and human beings. Pathogenic strains 
are frequently categorized into diarrheagenic E. coli 
(DEC) or extraintestinal pathogenic E. coli (ExPEC). 
DEC and ExPEC are further subcategorized into specific 
pathogroups based on the site or mode of infection [1]. 
Among the diseases caused by ExPEC are septicemia, 
neonatal meningitis, and urinary tract infections (UTI). 
Despite causing disease outside the gut, such bacteria 
have been shown to colonize the gastrointestinal (GI) 
tract of the host, in some cases even more efficiently than 
commensal E. coli strains [1]. The GI tract is the main 
reservoir for pathogenic E. coli [2], and in septicemic 
disease, the GI tract together with the urogenital tract, 
are important portals of E. coli entry [3].
ExPEC are genetically diverse and there are no con-
served virulence factors (VFs) or genetic characteristic 
that defines the ExPEC pathogroup or are essential for 
development of disease. Instead, septicemic bacteria pos-
sess a combination of VFs within the main groups of vir-
ulence traits (i.e. the adhesins, capsular synthesis, toxins, 
invasins and iron uptake systems). The set of VFs present 
in each septicemic strain enables the bacteria to defeat 
the host’s defense mechanisms and cause an infection [4]. 
The lack of common VFs among septicemic strains and 
the numerous possible combinations of VFs make the 
recognition of septicemic strains and the assessment of 
their pathogenic potential challenging.
Genomic analysis can provide clues to a strain’s viru-
lence and demonstrate its similarity to other pathogenic 
isolates. However, to truly assess a strain’s pathogenic 
potential, it must be tested in a biological assay or animal 
model. Cell culture as well as invertebrate and vertebrate 
models have been developed to study septicemic disease 
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and ExPEC virulence specifically. These models range 
from murine models aimed to differentiate pathogenic 
from nonpathogenic E. coli strains [5, 6] to the unicellular 
amoeba model, Dictyostelium discoideum, measuring the 
level of bacterial pathogenicity [7].
Zebrafish (Danio rerio) embryos has been shown to be 
a useful model organism for the study of host-pathogen 
interactions and the virulence potential of ExPEC strains 
[8]. During the early stages of development, the zebrafish 
immune system is composed solely of innate defenses, 
including phagocytes, NK cells, complement and toll-like 
receptors, and this corresponds to the immune system of 
neonatal lambs [9–11].
Escherichia coli O78 strain K46 was isolated from an 
outbreak of septicemia in neonatal lambs in Norway in 
2008 [12]. Previous genetic characterization could not 
explain the observed high virulence of this strain [12]. The 
aim of this study was to investigate the virulence potential 
of E. coli K46 in in vivo virulence assays such as a zebrafish 
septicemia model, a murine gut colonization model, and a 
murine urinary tract model, and in in vitro assays for the 
production of pili/fimbriae. In addition, the survival poten-
tial in the environment was examined in a biofilm assay.
Materials and methods
Bacterial strains
The septicemic E. coli K46 was used in all the experi-
ments in this study. Two uropathogenic E. coli strains, 
CFT073 and UTI89, and four enteric E. coli strains, des-
ignated Ctr 1- Ctr 4, were used as reference and control 
strains, respectively, for one or more of the experiments 
in this study (Table 1).
Media and conditions
The minimal medium M9 (6  g/L Na2HPO4, 3  g/L 
KH2PO4, 1  g/L NH4Cl, 0.5  g/L NaCl, 1  mM MgSO4, 
0.1 mM CaCl2, 0.1% glucose, 0.0025% nicotinic acid and 
16.5  µg/mL thiamine), YESCA (0.5  g/L yeast extract, 
10  g/L casamino acids) and Luria–Bertani (LB) broth 
were used in one or more of the experiments. The cul-
tures were grown overnight in an aerobic atmosphere at 
37 °C shaking at 225 rpm if not otherwise specified.
In the zebrafish trial, inocula were prepared by cen-
trifugation of 1 mL of static, 24 h M9 culture at approxi-
mately 7000 RCF for 2  min, and the pellet was washed 
once with 1 mL sterile PBS (Hyclone) and resuspended in 
275–550 µL PBS to obtain appropriate bacterial densities 
for microinjection.
In the murine gut colonization trial, 12 mL of a static 
overnight M9 culture was centrifuged at approximately 
8000 RCF for 10 min. The pellet was washed with 1 mL 
PBS, the centrifugation step repeated, and the pellet was 
resuspended in 500 µL sterile PBS. The number of colony 
forming units (CFU)/mL was measured after serial dilu-
tions and plating to LB plates. For recovery of E. coli 
K46 and the reference strain CFT073 in the murine gut 
colonization study, tetracycline (5 mg/mL) and chloram-
phenicol (10 mg/mL), respectively, were added to the LB 
plates as selective agents.
In the mouse UTI trial, 20  mL of a static overnight 
M9 culture was centrifuged at approximately 8000 RCF 
for 10 min at 20  °C and the pellet was resuspended in 
8 mL sterile PBS and diluted 1:10. Serial dilutions and 
plating on LB plates were done to quantify the infection 
dose.
Table 1 Overview over E. coli strains used in the study
a Previously referred to as belonging to phylogenetic group A, but is now regrouped to Group C [12].
Strain Source Characteristics Reference
E. coli wildtype strains
 K46 Septicemia, lamb O78
Tetracycline and sulfonamide resistant
Phylogenetic group Ca
[12]
 Ctr 1 Feces, healthy lamb Phylogenetic group B2 [12]
 Ctr 2 Feces, healthy lamb Phylogenetic group B1 [12]
 Ctr 3 Feces, healthy lamb Phylogenetic group B2 [12]
 Ctr 4 Feces, healthy lamb Phylogenetic group B2 [12]
 CFT073 Pyelonephritis, human O6:K2:H1
Cytotoxic
[31], [2]
 UTI89 Cystitis‑derived, human O18:K1:H7 [32]
E. coli recombinant strains
 CFT073‑ClmR CFT073 Chloramphenicol resistant [33]
 K46 pGEN‑GFP K46 Expresses destabilized green fluorescent protein (GFP) This study
 Ctr 1 pGEN‑GFP Ctr 1 Expresses destabilized GFP This study
 Ctr 2 pGEN‑GFP Ctr 2 Expresses destabilized GFP This study
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Zebrafish septicemia trials
To measure the virulence potential of E. coli K46 and the 
control strains Ctr 1 and Ctr 2, a zebrafish septicemia 
model was used as in [8]. Briefly, 48–54 h old zebrafish 
embryos were allocated in three groups of 18–20 
embryos each. Each fish embryo was kept separately 
during the experiment. The three groups were inocu-
lated with approximately 103 CFU of E. coli K46, Ctr 1 
or Ctr 2, into the bloodstream via the circulatory valley, 
resulting in rapid, systemic dispersal. Live and dead fish 
were counted at 6, 12, 14, 18, 24, 48 and 72 h post inoc-
ulum (hpi), but the 12, 14 and 18 time points were only 
included in one trial. Death was defined as the complete 
absence of heart rhythm and blood flow. To quantify bac-
terial burden during the course of infection, embryos 
from each infection group were collected at 6 and 12 hpi 
and individually homogenized with a mechanical PRO 
250 homogenizer (PRO Scientific) in 0.5  mL PBS con-
taining 0.5% Triton X-100. Homogenates were serially 
diluted and plated on LB agar, incubated overnight at 
37 °C and CFUs were counted. Both the survival trial and 
the quantification trial were run in biological duplicates.
To visually track the course of infection in real time, 
zebrafish embryos were also injected with 1–2  ×  103 
CFU of E. coli K46, Ctr 1 or Ctr 2 carrying pGEN-GFP 
(LVA) [8] for constitutive expression of destabilized green 
fluorescent protein (GFP) protein (GFP-marked strains). 
At 12 hpi embryos were fixed by incubation overnight at 
4  °C in PBS containing 4% paraformaldehyde in a light 
proof container. Fixed embryos were washed in PBS con-
taining 0.8% Triton X-100 in the dark for 4 × 20 min and 
then incubated for 10  min each in 30 and 50% glycerol 
before being transferred to a lightproof container and 
stored at 4  °C. Samples were imaged using an Olympus 
SZX10 stereomicroscope equipped with an Olympus 
DP72 camera.
Murine gut colonization trials
To measure E. coli K46’s ability to colonize the gastro-
intestinal tract, two groups of five 6–7  week old female 
CBA/J mice (Jackson Laboratory, USA) were anesthe-
tized by inhalation of isoflurane gas and gavaged with 
50 µL of approximately 3  ×  109 CFU of either E. coli 
K46 (resistant to tetracycline) or CFT073-ClmR (resist-
ant to chloramphenicol). The two groups were kept in 
separate cages, and each mouse was marked individually. 
Fecal matter from each mouse was collected on the day 
of inoculation to ensure the absence of any tetracycline 
and chloramphenicol resistant bacteria in the commen-
sal microbiota. Fecal samples were collected daily for 10 
consecutive days and after 12 days post inoculum (dpi). 
Approximately 100  mg of feces/mouse/day was resus-
pended in 900 µL 0.7% NaCl. Serial dilutions were plated 
on LB agar with either chloramphenicol or tetracycline 
and incubated overnight at 37  °C for quantification of 
CFT073-ClmR and E. coli K46, respectively. At 14 dpi the 
mice were anesthetized and euthanized by cervical dislo-
cation. The liver, kidney, bladder and intestines from the 
mice with E. coli K46 were homogenized in 0.25% Triton 
X-100, serially diluted in 0.7% NaCl and plated on LB 
plates with tetracycline. The mice showed no overt signs 
of sickness throughout the trial.
Mouse UTI trials
Transurethral catheterization as described by Wiles et al. 
[13] were performed in order to investigate whether E. 
coli K46 could be an original urinary tract pathogen (i.e. 
that the urogenital tract was the port of entry in the dis-
eased lambs). Eleven 7–8  week old female CBA/J mice 
(Jackson Laboratory, USA) were anesthetized by isoflu-
rane inhalation and slowly inoculated through the ure-
thra with a 50 µL bacterial suspension of approximately 
105–106 CFU of E. coli K46. The mice were euthanized 
3 days later by cervical dislocation under anesthesia, and 
the bladder and left kidney were homogenized separately 
in 1  mL of 0.025% Triton X-100. The suspensions were 
serially diluted, spread onto LB agar plates, and incubated 
for about 18 h at 37 °C, and CFU/g tissue were calculated.
Expression of fimH, curli fiber and cellulose biosynthesis
Type 1 pili and curli fimbriae are important factors in 
biofilm production, so the expression of these factors was 
investigated in E. coli K46 and the four control strains. 
The expression of fimH (adhesin of type 1 pili) was tested 
using a yeast agglutination assay. The strains were grown 
in static overnight LB cultures at 37 °C. 50 μL of PBS with 
1% yeast (Saccharomyces cerevisiae) and 150 μL of over-
night culture were pipetted onto a sterile microscope 
slide and mixed, and the ability to agglutinate was visu-
ally observed.
The expression of curli fiber was detected by growing 
the strains on Congo red plates (1% tryptone agar plates 
containing the dye Congo red) overnight at 30  °C. Red 
pigment in the colonies was deemed as positive for curli 
fiber [14].
Since the expression of cellulose could reduce the pro-
duction of biofilm [15], the bacterial strains were tested 
for their ability to synthesize cellulose on LB agar with 
0.02  % (w/v) calcofluor white. Plates were incubated for 
24 and 48 h at 30 °C, and then observed under UV light 
(366  nm) for the presence of fluorescence and thereby 
positive for the synthesis of cellulose [15].
Growth curves and biofilm formation
The ability to produce biofilm is an advantage in environ-
mental survival for a pathogenic strain, as well as survival 
Page 4 of 8Kjelstrup et al. Vet Res  (2017) 48:3 
within a host [16]. E. coli K46 and Ctr 1-Ctr 4 were tested 
for their ability to form biofilm in three different media; LB, 
M9 and YESCA. Each overnight culture was diluted 1:100 
in fresh medium, and four technical replicates of 100 μL of 
these dilutions were transferred to a flat-bottomed polysty-
rene 96-well microtiter plates with lids (NUNC). The plates 
were incubated at 30 °C statically for 48 h, the media was 
withdrawn, and the wells rinsed with water to remove any 
planktonic bacteria. 150 μL of 0.1% crystal violet solution 
was added to each well and incubated for 10 min at room 
temperature, the solution was removed and the wells were 
washed with water to remove any crystal violet unbound to 
biofilms before the microtiter plates were air dried without 
a lid for 30 min. 200 μL of solvent solution (DMSO) was 
added to solubilize stained biofilms and the plates were cov-
ered and incubated at room temperature, while shaking for 
15 min. Absorbance was obtained using a SynergyHTTR/
KC4 fluorimeter/luminometer (BioTek Instruments, Inc.) 
at 562 nm. Three biological replicates were made for each 
strain. The biofilm produced was measured by arbitrary 
units, where the mass of biofilm produced by the various 
strains was compared to the mass of biofilm produced by 
the reference strain UTI89.
To ensure that the observations were due to the strains’ 
ability to form biofilm in each medium and not their abil-
ity to grow in these media, growth curves for the five 
strains in the three media were obtained using a Bio-
screen C plate reader system (Growth Curves USA, Pis-
cataway, NJ, USA). The setup was parallel to the biofilm 
protocol regarding the preparation of the cultures, but 
200 μL diluted culture was used instead of 100 µL in each 
well. The trays were inserted into the microplate reader 
(Bioscreen) for 24  h with shaking, and bacterial growth 
was measured every 30 min at OD600.
Ethics approval
Mice used in this study were handled in accordance with 
protocols approved by the Institutional Animal Care and 
Use Committee (IACUC) at the University of Utah (Pro-
tocol number 10-02014), following US federal guidelines 
indicated by the Office of Laboratory Animal Welfare 
(OLAW) and described in the Guide for the Care and 
Use of Laboratory Animals, 8th Edition.
Zebrafish used in this study were handled in accord-
ance with IACUC-approved protocols following standard 
procedures.
Results
Escherichia coli K46 is highly virulent in the zebrafish 
bloodstream
Escherichia coli K46 proliferated readily in the zebrafish 
embryos and approximately 2 and 3 magnitude higher 
levels of bacteria were retrieved at 6 and 12 hpi, 
respectively, compared to the time point of inoculation 
(Figure 1B). Ctr 1 and Ctr 2 did not reach higher levels 
in the embryos (Figure 1B), and the bacteria were elimi-
nated within 24 hpi (data not shown). All of the embryos 
infected with Ctr 1 and Ctr 2 were still alive at 72 hpi (Fig-
ure 1A) and no signs of obvious disease were observed in 
these fish. Conversely, all the embryos challenged with E. 
coli K46 died between 12 and 18 hpi (Figure 1A).
Infection with GFP-labeled E. coli K46 showed that 
bacteria were located throughout the vasculature at 12 
hpi (Figure  2), while the zebrafish embryos inoculated 
with the GFP-marked Ctr 1 and Ctr 2 only showed back-
ground fluorescence at 12 hpi (data not shown). Together 
these results show that E. coli K46 is highly lethal in a 
zebrafish embryo model of infection and can replicate 
readily within the zebrafish bloodstream.
Escherichia coli K46 stably colonizes the gastrointestinal 
tract of mice
Following oral gavage into the gastrointestinal tract, E. 
coli K46 colonized the gut of all mice at an average con-
centration of 106 CFU/g feces throughout the 12 days of 
experiment. This was similar to what was seen for ExPEC 
reference strain CFT073 (Figure 3), indicating that E. coli 
K46 is an efficient colonizer of the mouse intestine.
Escherichia coli K46 colonizes the bladder poorly
Following transurethral catheterization of K46 into the 
bladder, bacteria could not be detected at 3 dpi in half of 
the mice. In the remaining mice, 103–104 CFU/g tissue were 
isolated at this time point (Figure 4). When bacterial titers in 
the kidneys were examined, two of the mice with bacteria in 
the bladder also had 105–107 CFU/g bacteria present in the 
kidneys. A similar titer of bacteria was also found in the kid-
ney of one mouse with no bacteria in the bladder (Figure 4). 
The finding of bacteria in the kidneys indicates that E. coli 
K46 has the ability to ascend in the urinary tract.
Escherichia coli K46 expresses fimH, curli fiber 
and produces cellulose
Escherichia coli K46 and Ctr 1, Ctr 3 and Ctr 4 were posi-
tive for fimH expression as measured by yeast agglutina-
tion. Escherichia coli K46 and E.  coli Ctr 4 were weakly 
positive for the expression of curli fiber and cellulose 
production as determined by growth on Congo Red and 
Calcofluor White plates (Table  2). These results suggest 
that E. coli K46 has all the requirements needed for bio-
film production.
Escherichia coli K46’s ability to produce biofilm depends 
on the trial conditions
In LB broth, both E. coli K46 and the control strains 
Ctr 1-Ctr 4 were poor biofilm producers (Figure  5A). 
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In YESCA media, Ctr 4 formed equal amount of bio-
film as ExPEC reference strain UTI89, while the other 
strains produced approximately 50% less (Figure 5C). In 
modified M9 minimal media, E. coli K46 and Ctr 1-Ctr 
3, formed biofilm at the same or higher level than UTI89, 
while Ctr 4 formed approximately 20% less biofilm than 
UTI89 (Figure  5B). The growth characteristics of all E. 
coli strains tested were similar within each media, but 
differences in growth rate and final OD were observed 
between different media conditions (Figures  5A–C). 
Together this data show that E. coli K46 produces biofilm 
most efficiently under stringent conditions in vitro.
Discussion
Fewer virulence factors (VFs) were detected in E. coli 
K46 than in half of the control strains isolated from 
healthy lambs, and none of the detected VFs were suffi-
cient to explain the observed lethality in the septicemic 
outbreak among the neonatal lambs [12]. Despite this 
lack of specific VFs, we show that E. coli K46 is excep-
tionally virulent in the zebrafish model, as it killed all the 
infected embryos within 24 hpi, while none of the E. coli 
control strains caused any lethality. This is underscored 
Figure 1 Survival plot and corresponding bacterial titers in zebrafish embryos. A Representative Kaplan–Meier survival plot of 48–54 h 
post fertilization zebrafish embryos inoculated with 103 CFU of E. coli K46, Ctr 1 or Ctr 2. Live and dead fish were counted at 6, 12, 14, 18, 24, 48 and 
72 h post inoculum. The lines for Ctr 1 and Ctr 2 coincide at 100% survival throughout the experiment. B The level of bacteria retrieved from the 
inoculated zebrafish at 6 and 12 h post inoculation (hpi). The horizontal bars indicate the median values for each group. Ctr 1 has two zero points at 
12 hpi which are not graphed.
Figure 2 Brightfield image of a zebrafish embryo inoculated 
with a fluorescent E. coli strain. A Brightfield image indicating the 
inoculation site of E. coli K46/pGEN‑GFP (LVA) in the circulatory valley 
(arrow). B At 12 hpi, the bacteria are located throughout the vascula‑
ture of the embryo, but with minimal intrusion into the surrounding 
tissues.
Gut colonization




















Figure 3 Gastrointestinal tract colonization in adult mice. The 
mice were gavaged with 1.5 × 108 CFU of E. coli K46 (tetracycline 
resistant) or the reference strain UPEC strain CFT073‑ClmR (chloram‑
phenicol resistant). The colonization was assessed at each of the 
indicated time points by enumerating CFU per gram feces of the 
inoculated strains. Data represent CFU/g feces ± SEM (n = 5 mice).
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by the zebrafish trial with the GFP marked E. coli K46, 
where the bacterial path from the infection site through 
the vasculature of the embryo is confirmed. The zebrafish 
trials correspond with the high virulence observed in the 
septicemic outbreak among the neonatal lambs, where 
all six lambs died after acute illness [12]. The clearance 
of the E. coli control strains from the zebrafish embryos 
is in accordance with other studies where avirulent E. coli 
K12 (DH5α) was phagocytosed and eliminated within 5 
h after infection [17]. While the zebrafish results do not 
explain the specific mechanisms behind the microbial 
pathogenesis, they do support our conviction that E. coli 
K46 is highly pathogenic. Our data also support the con-
clusion that bacterial factors and not only host factors, 
contributed significantly to the lethality in the lambs.
The results obtained in the zebrafish trials further 
support the use of zebrafish as a suitable model organ-
ism for studying pathogenicity in E. coli. The zebrafish 
(Danio rerio) has a well-developed immune system, 
which is similar to the mammalian immune system [18]. 
The model is also sensitive and hence applicable for 
examining pathogenicity and closely related strains of E. 
coli have been shown to display differences in virulence 
capability in the zebrafish model which correspond with 
differences in pathogenicity in the human host [8].
The bacterial species in the GI tract of humans and 
sheep are different from those in mice, but the condi-
tions and factors affecting bacterial competition within 
the mouse gut can to some extent be extrapolated to 
humans [19]. Nevertheless, it was somewhat surprising 
that E. coli K46 colonized the murine gut at the same 
high levels as the reference strain CFT073, which is rec-
ognized to be a very efficient colonizer of the mouse 
intestine [20]. In neonatal septicemia, the ewe may be 
the source of infection through contaminated fleece and 
udder after shedding pathogenic bacteria in the feces. 
The bacteria subsequently enter the lambs per os through 
suckling. From there the ingested bacteria likely colonize 
the infant gut and enter the bloodstream, resulting in 
septicemic disease. The portal of entry is not known in 
the E. coli K46 outbreak, but the strain’s significant abil-
ity to colonize the murine gut indicate that the gastroin-
testinal tract could be a possible entry route. If nothing 
else, the high and stable level of E. coli K46 in the mouse 
gut despite the absence of any selective pressure, shows 
that this strain has the essential prerequisites to outcom-
pete an intact microbiota and colonize the gut. Whether 
E. coli K46 would establish itself as part of the normal 
murine gut flora permanently is not known, as the mice 
experiment was ended after 2 weeks duration when the 
level of E. coli K46 was still high.
Infection in the bladder and a subsequent ascending 
infection to the kidneys is a common infection route 
of septicemia in humans [21]. E. coli K46 colonized the 
murine bladder poorly, which corresponds with the lack 
of pathological findings in the kidneys at autopsy of the 
mice (data not shown). This indicates that the urogeni-
tal tract is not a preferred entry route for the entrance of 
E. coli K46 into the bloodstream, at least not in mice. In 
two of three mice with E. coli in both the kidney and the 
bladder, the bacteria likely reached the kidney through 
an ascending infection. Bacterial reflux into the kidneys 
during transurethral catheterization is rare [22], but this 
might explain the retrieval of E. coli only in the kidney, 
and not in the bladder, in one of the mice.
Escherichia coli K46 expressed curli fiber and the type 
1 fimbriae fimH, in addition to possessing genes for other 
adhesins like afaE VIII, f17 fimbriae, prfB, bmaE and lpfA 
[12]. The expression of different fimbriae and the level of 
their expression may give the strain a selective advantage 
during colonization. Type 1 fimbriae (fimH) have been 
Figure 4 E. coli retrieved in the mural bladder and kidney fol-
lowing transurethral catheterization. CFU of E. coli K46 present in 
the bladder and kidney of female CBA/J mice 3 days after transure‑
thral catheterization of 105–106 CFU of E. coli K46. The ability to infect 
the organs was assessed as CFU per gram tissue. Horizontal bars 
denote mean values for each group (n = 11).
Table 2 Results of fimbriae expression and cellulose syn-
thesis
The expression of fimH and curli fiber and the production of cellulose in E. coli 
K46 and four E. coli control strains Ctr 1-Ctr 4.
a Weak reaction.
Strains FimH expression Curli fiber Cellulose synthesis
K46 + +a +a
Ctr 1 + − −
Ctr 2 − − −
Ctr 3 + − −
Ctr 4 + +a +a
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shown to be important in the adherence and invasion 
of bladder epithelial cells both in vitro and in mice [23]. 
Fimbriae may also play a role in the ability to form bio-
film. Along with their role in the formation of secreted 
IgA-mediated biofilm within the gut, several groups have 
reported that type 1 fimbriae (fimH) are critical for E. coli 
biofilm formation on abiotic surfaces [24–26]. Mutations 
in fimH have been reported to reduce E. coli attachment 
to polyvinyl chloride and other abiotic surfaces [24, 27]. 
The expression of fimH has significance in the formation 
of biofilm in M9, while the expression of curli fiber is an 
important factor in biofilm formation in YESCA [28]. 
This is not supported by our study, where Ctr 2 (fimH-
negative) formed biofilm at the same level as the refer-
ence strain in M9, while Ctr 4 (fimH-positive) did not. 
In YESCA, Ctr 4 formed biofilm on the same level as 
the reference strain, and at significant higher level than 
E. coli K46, despite both strains being weakly positive for 
curli fiber. In addition, a direct anti-biofilm role has been 
demonstrated for group II capsular polysaccharides [29], 
but since neither E. coli K46 nor Ctr 1-Ctr 4 contained 
genes for capsular synthesis this cannot explain the dif-
ference in biofilm production in the current study. One 
should keep in mind, however, that this method meas-
ures biomass and not cell viability, and that biofilm for-
mation in vivo and in the environment are influenced by 
other factors [30].
Cellulose is usually produced as an extracellular com-
ponent for mechanical and chemical protection and the 
expression of cellulose can reduce biofilm production 
[15]. However, the co-expression of cellulose and curli 
fiber can form a highly inert, hydrophobic extracellular 
matrix, called “bacterial wood” which surrounds the bac-
terial surface and function as a survival mechanism. The 
production of both cellulose and curli fiber in E. coli K46 
could increase its persistence in a farm environment.
The zebrafish lethality model supports our belief that E. 
coli K46 is highly pathogenic, and that the lamb lethality 
seen in the septicemic outbreak was likely due to a col-
lection of known and unknown bacterial virulence fac-
tors. The murine models show that E. coli K46 can stably 
colonize the intestinal microbiota and potentially provide 
a route of entry for infection. Known virulence genes 
essential for the high pathogenicity were not identified, 
but bacterial knockout mutants used in zebrafish chal-
lenge could be an interesting approach in future studies.
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Figure 5 Growth curves and biofilm formation of E. coli. A–C show representative growth curves in LB, M9, and in YESCA, respectively of E. coli 
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